Causes of Anaemia in End-Stage Renal Failure Patients

Anaemia is a common complication in patients with end-stage renal failure, primarily due to a decrease in the production of erythropoietin by the kidneys. Other causes of anaemia can include folate and vitamin B12 deficiency, uraemic inhibitors, and reduced half-life of circulating blood cells. The prevalence of anaemia in patients with chronic kidney disease (CKD) increases as eGFR levels decrease, with a prevalence of 12% in CKD patients. Folate deficiency and iron deficiency can also cause anaemia, but in this case, the anaemia is more likely related to poor kidney function. Deficiencies in granulocyte colony-stimulating factor and pyridoxine are less likely causes of anaemia in end-stage renal failure patients.

To determine the cause of the watery vaginal discharge in this patient, further information about her sexual history would be necessary. However, based on the appearance of her cervix, a diagnosis of Gonorrhoea is unlikely. Gonorrhoea typically presents with a green and purulent discharge, and is not often associated with an odour. Similarly, Chlamydia would likely cause more problems with the cervix and a more mucopurulent discharge. Herpes simplex does not typically cause vaginal discharge, but instead presents with ulcers or tingling sensations around the vulva. Thrush, or candidiasis, would likely cause more itching and have a thicker, cottage cheese-like consistency. Bacterial vaginosis is the most likely diagnosis, as it often presents with a fishy odour and a thin, watery discharge that may be green or white. It can be asymptomatic and does not typically cause irritation or soreness. Diagnosis can be confirmed with a vaginal pH > 4.5 and the presence of clue cells on microscopy. These findings are in line with BASHH guidelines.

Bacterial vaginosis (BV) is a condition where there is an overgrowth of anaerobic organisms, particularly Gardnerella vaginalis, in the vagina. This leads to a decrease in the amount of lactobacilli, which produce lactic acid, resulting in an increase in vaginal pH. BV is not a sexually transmitted infection, but it is commonly seen in sexually active women. Symptoms include a fishy-smelling vaginal discharge, although some women may not experience any symptoms at all. Diagnosis is made using Amsel’s criteria, which includes the presence of thin, white discharge, clue cells on microscopy, a vaginal pH greater than 4.5, and a positive whiff test. Treatment involves oral metronidazole for 5-7 days, with a cure rate of 70-80%. However, relapse rates are high, with over 50% of women experiencing a recurrence within 3 months. Topical metronidazole or clindamycin may be used as alternatives.

Bacterial vaginosis during pregnancy can increase the risk of preterm labor, low birth weight, chorioamnionitis, and late miscarriage. It was previously recommended to avoid oral metronidazole in the first trimester and use topical clindamycin instead. However, recent guidelines suggest that oral metronidazole can be used throughout pregnancy. The British National Formulary (BNF) still advises against using high-dose metronidazole regimes. Clue cells, which are vaginal epithelial cells covered with bacteria, can be seen on microscopy in women with BV.

Urgent Hospital Admission Required for Erythrodermic Psoriasis

Erythrodermic psoriasis is a severe dermatological emergency that requires urgent hospital admission. This is evident in a patient who presents with a drop in blood pressure, tachycardia, borderline pyrexia, and rigors. While the patient’s psoriasis needs more intensive management, it is not appropriate to manage erythroderma in the community.

The treatment for erythrodermic psoriasis includes supportive care, such as intravenous fluids, cool, wet dressings, and a systemic agent. The choice of a systemic agent depends on the patient and may involve rapid-acting therapies like ciclosporin or slower agents like methotrexate. However, it is important to note that starting any systemic agent requires investigations, including baseline blood tests and a viral screen, to ensure it is not contraindicated.

It is crucial to differentiate erythrodermic psoriasis from other dermatological emergencies like Stevens-Johnson syndrome/toxic epidermal necrolysis (TEN), which is a severe drug reaction associated with amoxicillin and anti-epileptic therapies. However, in this case, the patient’s history features a slow deterioration of pre-existing psoriasis, and the rash is not desquamating, and there are no oral lesions. Therefore, hospital admission is required for erythrodermic psoriasis.

It is essential to avoid repeating phototherapy in a patient with erythrodermic psoriasis as it can worsen the condition. In a well patient, phototherapy would not be reattempted six months after a poor response, and an alternate approach would most likely be sought.

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in young males, with a sex ratio of 3:1, and typically presents with lower back pain and stiffness that develops gradually. The stiffness is usually worse in the morning and improves with exercise, while pain at night may improve upon getting up. Clinical examination may reveal reduced lateral and forward flexion, as well as reduced chest expansion. Other features associated with ankylosing spondylitis include apical fibrosis, anterior uveitis, aortic regurgitation, Achilles tendonitis, AV node block, amyloidosis, cauda equina syndrome, and peripheral arthritis (more common in females).

Giardiasis: A Protozoal Parasite Causing Diarrhoeal Illness

Giardiasis is a diarrhoeal disease caused by the flagellate protozoan Giardia intestinalis (previously known as G. lamblia). It is prevalent in areas with poor sanitation and can cause asymptomatic colonisation or acute or chronic diarrhoeal illness. Travellers to highly endemic areas are at high risk of infection. Ingestion of as few as ten Giardia cysts can cause infection. Diarrhoea is the most common symptom of acute Giardia infection, occurring in 90% of symptomatic subjects. The traditional basis of diagnosis is identification of G. intestinalis trophozoites or cysts in the stool of infected patients via stool ova and parasite examination. Standard treatment consists of antibiotic therapy, and metronidazole is the most commonly prescribed antibiotic for this condition. Giardia infection may occur more commonly in families with X-linked agammaglobulinaemia and in sexually active men who have sex with men (MSM).

Autoimmune Diseases: Understanding the Causes and Symptoms

Autoimmune diseases are conditions where the body’s immune system mistakenly attacks its own tissues. Here are some examples of autoimmune diseases and their causes and symptoms:

Coeliac Disease: This disease is caused by gluten sensitivity and results in chronic diarrhoea, weight loss, and fatigue. It is caused by an autoimmune reaction to glutenin or gliadin, which are gluten proteins found in wheat.

Pemphigus Vulgaris: This rare autoimmune disease causes blistering to the skin and mucosal surfaces. It is caused by autoantibodies against desmoglein.

Graves’ Disease: This autoimmune disease of the thyroid results in hyperthyroidism. It is associated with anti-thyroid-stimulating hormone receptor antibodies.

Systemic Lupus Erythematosus (SLE): SLE is a multisystem autoimmune disease associated with a wide number of autoantibodies, including anti-nuclear antibody (ANA), anti-double-stranded (ds) DNA, anti-Smith, anti-SSA, anti-ribosomal P, anti-RNP, and anti-histone antibodies.

Type I Diabetes Mellitus (T1DM): T1DM is an autoimmune disease resulting in destruction of the islet cells. Islet cell autoantibodies and antibodies to insulin have been described.

Understanding the causes and symptoms of autoimmune diseases can help with early diagnosis and treatment.

Minimal change disease is a condition that typically presents as nephrotic syndrome, with children accounting for 75% of cases and adults accounting for 25%. While most cases are idiopathic, around 10-20% have a known cause, such as certain drugs, Hodgkin’s lymphoma, thymoma, or infectious mononucleosis. The pathophysiology of the disease involves T-cell and cytokine-mediated damage to the glomerular basement membrane, resulting in polyanion loss and reduced electrostatic charge, which increases glomerular permeability to serum albumin. The disease is characterized by nephrotic syndrome, normotension (hypertension is rare), and highly selective proteinuria, with only intermediate-sized proteins such as albumin and transferrin leaking through the glomerulus. Renal biopsy shows normal glomeruli on light microscopy, but electron microscopy reveals fusion of podocytes and effacement of foot processes.

Management of minimal change disease typically involves oral corticosteroids, which are effective in 80% of cases. For steroid-resistant cases, cyclophosphamide is the next step. The prognosis for the disease is generally good, although relapse is common. Approximately one-third of patients have just one episode, one-third have infrequent relapses, and one-third have frequent relapses that stop before adulthood.

Primary dysmenorrhoea is best treated with NSAIDs like mefenamic acid, which are the first line of treatment according to NICE guidelines. Paracetamol can be used if NSAIDs are not suitable, and a combination of both can be tried if NSAIDs alone are not effective. Hormonal options like the combined oral contraceptive pill can also be considered, but contraindications must be ruled out. The intrauterine device or copper coil is not recommended for this patient due to the risk of heavier bleeding. Instead, the intrauterine system or Mirena coil can be offered as an alternative option. While the IUS is the first-line treatment for menorrhagia, NSAIDs are the initial choice for primary dysmenorrhoea. It is important to consider the patient’s plans for conception when deciding on treatment options.

Dysmenorrhoea is a condition where women experience excessive pain during their menstrual period. There are two types of dysmenorrhoea: primary and secondary. Primary dysmenorrhoea affects up to 50% of menstruating women and is not caused by any underlying pelvic pathology. It usually appears within 1-2 years of the menarche and is thought to be partially caused by excessive endometrial prostaglandin production. Symptoms include suprapubic cramping pains that may radiate to the back or down the thigh, and pain typically starts just before or within a few hours of the period starting. NSAIDs such as mefenamic acid and ibuprofen are effective in up to 80% of women, and combined oral contraceptive pills are used second line for management.

Secondary dysmenorrhoea, on the other hand, typically develops many years after the menarche and is caused by an underlying pathology. The pain usually starts 3-4 days before the onset of the period. Causes of secondary dysmenorrhoea include endometriosis, adenomyosis, pelvic inflammatory disease, intrauterine devices, and fibroids. Clinical Knowledge Summaries recommend referring all patients with secondary dysmenorrhoea to gynaecology for investigation. It is important to note that the intrauterine system (Mirena) may help dysmenorrhoea, but this only applies to normal copper coils.

Pregnant women at 16-32 weeks are given the option to receive the pertussis vaccine.

Whooping Cough: Causes, Symptoms, Diagnosis, and Management

Whooping cough, also known as pertussis, is a contagious disease caused by the bacterium Bordetella pertussis. It is commonly found in children, with around 1,000 cases reported annually in the UK. The disease is characterized by a persistent cough that can last up to 100 days, hence the name cough of 100 days.

Infants are particularly vulnerable to whooping cough, which is why routine immunization is recommended at 2, 3, 4 months, and 3-5 years. However, neither infection nor immunization provides lifelong protection, and adolescents and adults may still develop the disease.

Whooping cough has three phases: the catarrhal phase, the paroxysmal phase, and the convalescent phase. The catarrhal phase lasts around 1-2 weeks and presents symptoms similar to a viral upper respiratory tract infection. The paroxysmal phase is characterized by a severe cough that worsens at night and after feeding, and may be accompanied by vomiting and central cyanosis. The convalescent phase is when the cough subsides over weeks to months.

To diagnose whooping cough, a person must have an acute cough that has lasted for 14 days or more without another apparent cause, and have one or more of the following features: paroxysmal cough, inspiratory whoop, post-tussive vomiting, or undiagnosed apnoeic attacks in young infants. A nasal swab culture for Bordetella pertussis is used to confirm the diagnosis, although PCR and serology are increasingly used.

Infants under 6 months with suspected pertussis should be admitted, and in the UK, pertussis is a notifiable disease. An oral macrolide, such as clarithromycin, azithromycin, or erythromycin, is indicated if the onset of the cough is within the previous 21 days to eradicate the organism and reduce the spread. Household contacts should be offered antibiotic prophylaxis, although antibiotic therapy has not been shown to alter the course of the illness. School exclusion is recommended for 48 hours after commencing antibiotics or 21 days from onset of symptoms if no antibiotics are given.

Complications of whooping cough include subconjunctival haemorrhage, pneumonia, bronchiectasis, and

According to NICE (2017) guidelines, patients with asthma should be prescribed a SABA as the first step of treatment. However, if a patient experiences symptoms three or more times per week or night waking, they should also be prescribed a low-dose ICS inhaler as the second step of treatment. This is also necessary for patients who have had an acute exacerbation requiring oral corticosteroids in the past two years. In this case, the patient’s symptoms are not well-controlled with a SABA alone, and she experiences frequent symptoms and night waking. Therefore, she requires a low-dose ICS inhaler, and the only option available is budesonide.

Adding a salmeterol inhaler is not appropriate at this stage, as LABAs are only used as the fourth step of treatment if a patient is not controlled with a SABA, low-dose ICS, and a trial of LTRAs. Similarly, adding montelukast and a beclomethasone inhaler is not appropriate, as LTRAs are only added if a patient is still not controlled on a low-dose ICS and a SABA. However, it may be appropriate to trial beclomethasone without montelukast.

Continuing with the current salbutamol-only treatment is not appropriate, as the patient’s asthma is poorly controlled, which increases the risk of morbidity and mortality. Regular salbutamol has no role in the management of asthma, as it does not improve outcomes and may even worsen them by downregulating beta receptors that are important for bronchodilation.

The management of asthma in adults has been updated by NICE in 2017, following the 2016 BTS guidelines. One of the significant changes is in ‘step 3’, where patients on a SABA + ICS whose asthma is not well controlled should be offered a leukotriene receptor antagonist instead of a LABA. NICE does not follow the stepwise approach of the previous BTS guidelines, but to make the guidelines easier to follow, we have added our own steps. The steps range from newly-diagnosed asthma to SABA +/- LTRA + one of the following options, including increasing ICS to high-dose, a trial of an additional drug, or seeking advice from a healthcare professional with expertise in asthma. Maintenance and reliever therapy (MART) is a form of combined ICS and LABA treatment that is only available for ICS and LABA combinations in which the LABA has a fast-acting component. It should be noted that NICE does not recommend changing treatment in patients who have well-controlled asthma simply to adhere to the latest guidance. The definitions of what constitutes a low, moderate, or high-dose ICS have also changed, with <= 400 micrograms budesonide or equivalent being a low dose, 400 micrograms - 800 micrograms budesonide or equivalent being a moderate dose, and > 800 micrograms budesonide or equivalent being a high dose for adults.

It is essential to refer patients suspected of having AMD to ophthalmology urgently within 1 week for a formal diagnosis. This is because if the diagnosis is wet AMD, anti-VEGF injections can be administered, which will improve the patient’s long-term visual outcome. Even if drusen is present, which is more indicative of dry AMD, an urgent referral should still be made within 1 week. Delaying the referral for a month will postpone the formal diagnosis and treatment commencement for the patient. While multi-vitamins may be beneficial for dry AMD, it is not the next step in management. Atorvastatin is used to lower blood cholesterol levels and is not effective in treating drusen.

Age-related macular degeneration (ARMD) is a common cause of blindness in the UK, characterized by the degeneration of the central retina (macula) and the formation of drusen. It is more prevalent in females and is strongly associated with advancing age, smoking, family history, and conditions that increase the risk of ischaemic cardiovascular disease. ARMD can be classified into two forms: dry and wet. Dry ARMD is more common and is characterized by drusen, while wet ARMD is characterized by choroidal neovascularisation and carries a worse prognosis. Clinical features of ARMD include subacute onset of visual loss, difficulties in dark adaptation, and visual disturbances such as photopsia and glare.

To diagnose ARMD, slit-lamp microscopy and color fundus photography are used to identify any pigmentary, exudative, or haemorrhagic changes affecting the retina. Fluorescein angiography and indocyanine green angiography may also be used to visualize changes in the choroidal circulation. Treatment for dry ARMD involves a combination of zinc with anti-oxidant vitamins A, C, and E, which has been shown to reduce disease progression by around one third. For wet ARMD, anti-VEGF agents such as ranibizumab, bevacizumab, and pegaptanib are used to limit disease progression and stabilize or reverse visual loss. Laser photocoagulation may also be used to slow progression, but anti-VEGF therapies are usually preferred due to the risk of acute visual loss after treatment.

In summary, ARMD is a common cause of blindness in the UK that is strongly associated with advancing age, smoking, and family history. It can be classified into dry and wet forms, with wet ARMD carrying a worse prognosis. Diagnosis involves the use of various imaging techniques, and treatment options include a combination of zinc and anti-oxidant vitamins for dry ARMD and anti-VEGF agents or laser photocoagulation for wet ARMD.

Guidelines for Emergency Oxygen Therapy

The British Thoracic Society has updated its guidelines for emergency oxygen therapy in 2017. The guidelines recommend that in critically ill patients, such as those experiencing anaphylaxis or shock, oxygen should be administered via a reservoir mask at 15 l/min. However, certain conditions, such as stable myocardial infarction, are excluded from this recommendation.

The guidelines also provide specific oxygen saturation targets for different patient groups. Acutely ill patients should aim for a saturation range of 94-98%, while patients at risk of hypercapnia, such as those with COPD, should aim for a lower range of 88-92%. Oxygen therapy should be reduced in stable patients with satisfactory oxygen saturation.

For COPD patients, a 28% Venturi mask at 4 l/min should be used prior to availability of blood gases. The target oxygen saturation range for these patients should be 88-92% if they have risk factors for hypercapnia but no prior history of respiratory acidosis. If the pCO2 is normal, the target range can be adjusted to 94-98%.

The guidelines also highlight situations where oxygen therapy should not be used routinely if there is no evidence of hypoxia. These include myocardial infarction and acute coronary syndromes, stroke, obstetric emergencies, and anxiety-related hyperventilation.

Overall, these guidelines provide clear recommendations for the administration of emergency oxygen therapy in different patient groups and situations.

For symptomatic men with Chlamydia, it is recommended to notify all sexual partners from the 4 weeks prior to the onset of symptoms. As for women and asymptomatic men, all sexual partners from the last 6 months or the most recent partner should be notified. Pregnant women should undergo a test of cure (TOC) 6 weeks after infection, according to BASHH guidelines. Performing a TOC earlier than 6 weeks may result in a false positive due to the presence of nonviable Chlamydia DNA on the NAAT. However, uncomplicated Chlamydia infection in men and non-pregnant women does not require a routine TOC.

Chlamydia is a common sexually transmitted infection caused by Chlamydia trachomatis. It is prevalent in the UK, with approximately 1 in 10 young women affected. The incubation period is around 7-21 days, but many cases are asymptomatic. Symptoms in women include cervicitis, discharge, and bleeding, while men may experience urethral discharge and dysuria. Complications can include epididymitis, pelvic inflammatory disease, and infertility.

Traditional cell culture is no longer widely used for diagnosis, with nuclear acid amplification tests (NAATs) being the preferred method. Testing can be done using urine, vulvovaginal swab, or cervical swab. Screening is recommended for sexually active individuals aged 15-24 years, and opportunistic testing is common.

Doxycycline is the first-line treatment for Chlamydia, with azithromycin as an alternative if doxycycline is contraindicated or not tolerated. Pregnant women may be treated with azithromycin, erythromycin, or amoxicillin. Patients diagnosed with Chlamydia should be offered partner notification services, with all contacts since the onset of symptoms or within the last six months being notified and offered treatment.

Management of New-Onset Dyspepsia in a Middle-Aged Patient

When a middle-aged patient presents with new-onset dyspepsia, it is important to take a thorough clinical history to rule out more serious conditions such as malignancy. A 4-week course of full-dose PPI is typically recommended, although there is no clear evidence on whether this or Helicobacter pylori testing should be done first. If PPIs are used, a 2-week washout period is necessary before testing for H. pylori to avoid false-negative results.

While alginate preparations like Gaviscon® can be used to inhibit gastric acid reflux, it may be more appropriate to increase the PPI dose if the patient has already experienced some improvement with this medication. However, if the patient exhibits ‘red flag’ symptoms like gastrointestinal bleeding, anorexia, weight loss, dysphagia, or the presence of an epigastric mass, urgent endoscopy is necessary. Endoscopy is also recommended for patients over 55 with persistent, unexplained dyspepsia that has not responded well to PPIs.

Finally, while this patient’s BMI is on the higher end of the healthy range, referral to a dietician is unlikely to be necessary unless there are specific concerns about weight loss measures. Overall, a comprehensive approach to managing new-onset dyspepsia in middle-aged patients involves careful consideration of symptoms, medication options, and potential underlying conditions.

The recommended first-line antibiotic for patients with low severity community-acquired pneumonia (CAP) is oral amoxicillin. Therefore, it is appropriate to discharge this patient with oral amoxicillin as they present with symptoms of CAP, including a new cough, temperature, purulent sputum, and focal chest signs. While a chest x-ray could confirm the diagnosis, it is not usually necessary for suspected CAP managed in primary care. The patient’s CRB-65 score is 0, indicating that they can be managed in the community. Hospitalization may be required for patients with higher scores or clinical factors that increase the risk of complications, but this is not the case for this patient. Discharge with oral clarithromycin or doxycycline is not appropriate as there is no indication that amoxicillin is unsuitable as the first-line antibiotic.

Pneumonia is a serious respiratory infection that requires prompt assessment and management. In the primary care setting, the CRB65 criteria are used to stratify patients based on their risk of mortality. Patients with a score of 0 are considered low risk and may be treated at home, while those with a score of 3 or 4 are high risk and require urgent admission to hospital. The use of a point-of-care CRP test can help guide antibiotic therapy. In the secondary care setting, the CURB65 criteria are used, which includes an additional criterion of urea > 7 mmol/L. Chest x-rays and blood and sputum cultures are recommended for intermediate or high-risk patients. Treatment for low-severity community acquired pneumonia typically involves a 5-day course of amoxicillin, while moderate and high-severity cases may require dual antibiotic therapy for 7-10 days. Discharge criteria and advice post-discharge are also provided, including information on expected symptom resolution timeframes and the need for a repeat chest x-ray at 6 weeks.

Venous thromboembolism (VTE) is a serious condition that can lead to severe health complications and even death. However, it is preventable. The National Institute for Health and Care Excellence (NICE) has updated its guidelines for 2018 to provide recommendations for the assessment and management of patients at risk of VTE in hospital. All patients admitted to the hospital should be assessed individually to identify risk factors for VTE development and bleeding risk. The department of health’s VTE risk assessment tool is recommended for medical and surgical patients. Patients with certain risk factors, such as reduced mobility, surgery, cancer, and comorbidities, are at increased risk of developing VTE. After assessing a patient’s VTE risk, healthcare professionals should compare it to their risk of bleeding to decide whether VTE prophylaxis should be offered. If indicated, VTE prophylaxis should be started as soon as possible.

There are two types of VTE prophylaxis: mechanical and pharmacological. Mechanical prophylaxis includes anti-embolism stockings and intermittent pneumatic compression devices. Pharmacological prophylaxis includes fondaparinux sodium, low molecular weight heparin (LMWH), and unfractionated heparin (UFH). The choice of prophylaxis depends on the patient’s individual risk factors and bleeding risk.

In general, medical patients deemed at risk of VTE after individual assessment are started on pharmacological VTE prophylaxis, provided that the risk of VTE outweighs the risk of bleeding and there are no contraindications. Surgical patients at low risk of VTE are treated with anti-embolism stockings, while those at high risk are treated with a combination of stockings and pharmacological prophylaxis.

Patients undergoing certain surgical procedures, such as hip and knee replacements, are recommended to receive pharmacological VTE prophylaxis to reduce the risk of VTE developing post-surgery. For fragility fractures of the pelvis, hip, and proximal femur, LMWH or fondaparinux sodium is recommended for a month if the risk of VTE outweighs the risk of bleeding.

Healthcare professionals should advise patients to stop taking their combined oral contraceptive pill or hormone replacement therapy four weeks before surgery and mobilize them as soon as possible after surgery. Patients should also ensure they are hydrated. By following these guidelines, healthcare professionals can help prevent VTE and improve patient outcomes.

Common Skin Pigmentation Disorders

Skin pigmentation disorders are conditions that affect the color of the skin. Here are some of the most common ones:

Vitiligo: This rare condition is believed to be caused by the immune system attacking melanocytes, resulting in patches of skin with no pigment. It is more common in people of African descent.

Albinism: This genetic disorder reduces the activity of tyrosinase in melanocytes, resulting in a complete lack of pigment in the skin, hair, and eyes.

Melanoma: This is a type of skin cancer that develops from melanocytes. It is characterized by irregular, highly pigmented moles.

Melasma: This condition causes increased pigmentation, usually under the eyes. It is common in pregnant women and users of oral contraceptives.

Pityriasis alba: This condition causes white, scaly patches on the face, and is most commonly seen in children.

Understanding these skin pigmentation disorders can help individuals identify and manage them effectively.

Legionella is characterized by typical symptoms such as flu-like illness, dry cough, confusion, and relative bradycardia. Blood tests may reveal hyponatremia.

Outbreaks of Legionella pneumonia often occur in communities with shared water supplies, as hinted at in the question with the reference to the recent conference in Spain. This type of pneumonia frequently affects both lungs, as seen in the question. Additionally, Legionella can cause abnormal liver function tests and hyponatremia, which can lead to confusion in some cases, although this is not mentioned in the question.

The mention of unprotected sex is a distractor, as it would take years for HIV infection to make a person susceptible to infections like TB and Pneumocystis jiroveci.

Legionnaire’s Disease: Symptoms, Diagnosis, and Management

Legionnaire’s disease is a type of pneumonia caused by the Legionella pneumophilia bacterium, which is commonly found in water tanks. It is not transmitted from person to person. Symptoms of the disease include flu-like symptoms such as fever, dry cough, confusion, and lymphopaenia. Other features include relative bradycardia, hyponatraemia, and deranged liver function tests. Pleural effusion is seen in around 30% of patients.

Diagnosis of Legionnaire’s disease can be done through a urinary antigen test. Treatment involves the use of erythromycin or clarithromycin. Chest x-ray features of the disease are non-specific but may include patchy consolidation with a mid-to-lower zone predominance.

Compared to Mycoplasma pneumonia, Legionnaire’s disease has distinct differences in symptoms and diagnostic methods. It is important to be aware of the potential for Legionnaire’s disease in cases where water tanks or air-conditioning systems may be involved, as early diagnosis and treatment can lead to better outcomes.

Vitreous hemorrhage caused by proliferative retinopathy is more frequently observed in individuals with T1DM compared to T2DM. This is due to the presence of retinal neovascularization, which results in fragile blood vessels that are susceptible to bleeding. Conversely, vitreous hemorrhage is not typically associated with background, pre-proliferative diabetic retinopathy, or diabetic maculopathy as these conditions do not involve retinal neovascularization.

Understanding Diabetic Retinopathy

Diabetic retinopathy is a leading cause of blindness among adults aged 35-65 years old. The condition is caused by hyperglycemia, which leads to abnormal metabolism in the retinal vessel walls and damage to endothelial cells and pericytes. This damage causes increased vascular permeability, resulting in exudates seen on fundoscopy. Pericyte dysfunction predisposes to the formation of microaneurysms, while neovascularization is caused by the production of growth factors in response to retinal ischemia.

Patients with diabetic retinopathy are classified into those with non-proliferative diabetic retinopathy (NPDR), proliferative retinopathy (PDR), and maculopathy. NPDR is further classified into mild, moderate, and severe, depending on the presence of microaneurysms, blot hemorrhages, hard exudates, cotton wool spots, venous beading/looping, and intraretinal microvascular abnormalities. PDR is characterized by retinal neovascularization, which may lead to vitreous hemorrhage, and fibrous tissue forming anterior to the retinal disc. Maculopathy is based on location rather than severity and is more common in Type II DM.

Management of diabetic retinopathy involves optimizing glycaemic control, blood pressure, and hyperlipidemia, as well as regular review by ophthalmology. Treatment options include intravitreal vascular endothelial growth factor (VEGF) inhibitors for maculopathy, regular observation for non-proliferative retinopathy, and panretinal laser photocoagulation and intravitreal VEGF inhibitors for proliferative retinopathy. Vitreoretinal surgery may be necessary in cases of severe or vitreous hemorrhage.

Imaging Guidelines for Urinary Tract Infections in Children

Urinary tract infections (UTIs) are common in children and can be divided into upper and lower UTIs. Current guidelines recommend different imaging investigations based on the type of UTI and the child’s age. For infants and children aged ≥6 months with a first-time UTI that responds to treatment, routine ultrasonography is not recommended unless the child has an atypical UTI. Micturating cystourethrography (MCUG) is indicated if renal and bladder ultrasonography reveals hydronephrosis, scarring, or other findings that suggest high-grade vesicoureteral reflux (VUR) or obstructive uropathy. Ultrasonography of the urinary tract is the imaging study of choice in children with a UTI, and it is useful in excluding obstructive uropathy and identifying renal damage caused by pyelonephritis. Technectium-99m-labelled dimercaptosuccinic acid (99mTc-DMSA) is a scintigraphic agent that can be used to assess acute pyelonephritis, renal cortical scarring, and the identification of a malpositioned kidney. However, no imaging is required for a typical, non-recurrent UTI in a child aged ≥3 years. Atypical UTI features include being seriously ill, having poor urine flow, an abdominal or bladder mass, raised creatinine, septicaemia, failure to respond to treatment with suitable antibiotics within 48 hours, or infection with non-E. coli organisms.

Lichen sclerosus is a condition characterized by itchy white spots that are commonly observed on the vulva of older women. While candida can also cause itching and white patches, it would not result in lesions appearing on the inner thigh as well.

Understanding Lichen Sclerosus

Lichen sclerosus, previously known as lichen sclerosus et atrophicus, is an inflammatory condition that commonly affects the genitalia, particularly in elderly females. This condition leads to the atrophy of the epidermis, resulting in the formation of white plaques. The most prominent feature of lichen sclerosus is the presence of white patches that may scar. Patients may also experience itching and pain during intercourse or urination.

Diagnosis of lichen sclerosus is usually made based on clinical examination, but a biopsy may be performed if atypical features are present. Management of this condition involves the use of topical steroids and emollients. Patients with lichen sclerosus are at an increased risk of developing vulval cancer, and routine follow-up is necessary to monitor for any changes.

The Royal College of Obstetricians and Gynaecologists advise against performing a skin biopsy if a diagnosis can be made on clinical examination. However, a biopsy may be necessary if the patient fails to respond to treatment or if there is a suspicion of neoplastic change. The British Association of Dermatologists also recommends a biopsy if there are atypical features or diagnostic uncertainty. Patients under routine follow-up will need a biopsy if there is a suspicion of neoplastic change, if the disease fails to respond to treatment, if there is extragenital lichen sclerosus, or if second-line therapy is to be used.

Understanding lichen sclerosus is important for early diagnosis and management of this condition. Patients with this condition should seek medical attention if they experience any symptoms or changes in their condition.

Differentiating between types of arthritis: A case study

In this case study, a patient presents with bony swelling at the DIP and PIP joints of the hands. It is important to differentiate between various types of arthritis to make an accurate diagnosis and provide appropriate treatment.

Osteoarthritis (OA) is characterized by loss of articular cartilage and overgrowth of underlying bone, commonly affecting the hips, knees, and small hand joints. Pain and swelling are common presenting features, along with crepitus on examination. Heberden’s and Bouchard’s nodes may also be present.

Osteoporosis, on the other hand, is a condition of reduced bone density and increased fragility, often diagnosed following a low-impact fracture or screening of high-risk patients. Pain and bony swelling are not typical features of osteoporosis.

Psoriatic arthritis is an inflammatory seronegative spondyloarthropathy associated with psoriasis, commonly affecting the hands but not causing the changes described in this case. Dactylitis is a usual examination finding with psoriatic arthritis.

Reactive arthritis is characterized by a triad of urethritis, conjunctivitis, and arthritis following an infection. It typically presents as an acute, asymmetrical lower-limb arthritis, occurring a few days to weeks after the initial infection.

Rheumatoid arthritis (RA) presents most often in women between the ages of 35 and 55 with symmetrical polyarticular arthritis, most often in the small joints of the hands or feet. Swelling is present at the metacarpophalangeal and PIP joints of the hands, along with other signs such as swan neck and Boutonnière deformities of the fingers, ulnar deviation of fingers, and Z deformity of the thumb.

In conclusion, careful examination and consideration of various types of arthritis are necessary for an accurate diagnosis and appropriate treatment plan.

Common Antibiotics and Antifungals: Uses and Dosages

Metronidazole, Azithromycin, Co-amoxiclav, Fluconazole, and Nystatin are common antibiotics and antifungals used to treat various infections. Metronidazole is recommended for bacterial vaginosis and can be taken orally or applied topically. Azithromycin is used for Chlamydia, gonorrhea, and chancroid. Co-amoxiclav is a broad-spectrum antibiotic used for respiratory and urinary tract infections, among others. Fluconazole is an oral antifungal used for severe oral and vaginal candidiasis. Nystatin is an antifungal used for oral candidiasis. Dosages and treatment durations vary depending on the specific infection being treated.

Prophylaxis for contacts of patients with meningococcal meningitis now favors the use of oral ciprofloxacin over rifampicin.

The investigation and management of suspected bacterial meningitis are intertwined due to the potential negative impact of delayed antibiotic treatment. Patients should be urgently transferred to the hospital, and an ABC approach should be taken initially. A lumbar puncture should be delayed in certain circumstances, and IV antibiotics should be given as a priority if there is any doubt. The bloods and CSF should be tested for various parameters, and prophylaxis should be offered to households and close contacts of patients affected with meningococcal meningitis.

A prolapsed disc is suspected based on the patient’s symptoms. However, even if an MRI scan confirms this diagnosis, the initial management would remain the same as most patients respond well to conservative treatment like physiotherapy.

Understanding Prolapsed Disc and its Features

A prolapsed lumbar disc is a common cause of lower back pain that can lead to neurological deficits. It is characterized by clear dermatomal leg pain, which is usually worse than the back pain. The pain is often aggravated when sitting. The features of the prolapsed disc depend on the site of compression. For instance, L3 nerve root compression can cause sensory loss over the anterior thigh, weak quadriceps, reduced knee reflex, and a positive femoral stretch test. On the other hand, L4 nerve root compression can lead to sensory loss in the anterior aspect of the knee, weak quadriceps, reduced knee reflex, and a positive femoral stretch test.

The management of prolapsed disc is similar to that of other musculoskeletal lower back pain. It involves analgesia, physiotherapy, and exercises. According to NICE, the first-line treatment for back pain without sciatica symptoms is NSAIDs +/- proton pump inhibitors, rather than neuropathic analgesia. If the symptoms persist after 4-6 weeks, referral for consideration of MRI is appropriate. Understanding the features of prolapsed disc can help in the diagnosis and management of this condition.

Experiencing a grief reaction is common after a significant loss, and it can manifest with physical and psychological symptoms that can last up to six months. It can be challenging to differentiate between depression and a typical grief reaction since they share similar symptoms. However, a regular grief reaction typically lasts less than six months, while depression can persist for a more extended period. Although she has brief visual hallucinations, psychosis is an incorrect diagnosis since she does not exhibit any other indications.

Grief is a natural response to the death of a loved one and does not always require medical intervention. However, understanding the potential stages of grief can help determine if a patient is experiencing a normal reaction or a more significant problem. The most common model of grief divides it into five stages: denial, anger, bargaining, depression, and acceptance. It is important to note that not all patients will experience all five stages. Atypical grief reactions are more likely to occur in women, sudden and unexpected deaths, problematic relationships before death, and lack of social support. Delayed grief, which occurs when grieving does not begin for more than two weeks, and prolonged grief, which is difficult to define but may last beyond 12 months, are features of atypical grief reactions.

Effects of Cortisol on the Body: Misconceptions and Clarifications

Cortisol, a hormone produced by the adrenal glands, plays a crucial role in regulating various bodily functions. However, there are some misconceptions about the effects of cortisol on the body. Here are some clarifications:

Hirsutism: Elevated cortisol levels can cause a condition called Cushingoid, which may result in hirsutism in women. This is characterized by excessive hair growth in areas such as the face, chest, and back.

Hypoglycemia: Contrary to popular belief, cortisol does not cause hypoglycemia. Instead, it increases gluconeogenesis (the production of glucose from non-carbohydrate sources) and reduces glucose uptake in peripheral tissues, resulting in hyperglycemia.

Enhanced glucose uptake: Cortisol actually has the opposite effect on glucose uptake. It reduces the uptake of glucose into peripheral tissues and accelerates gluconeogenesis.

Hypotension: Patients with adrenal hyperfunction (excessive cortisol production) often suffer from hypertension (high blood pressure), not hypotension (low blood pressure). This is because excessive mineralocorticoids are released, which can cause fluid retention and increase blood pressure.

Hypocalciuria: Cortisol can lead to osteopenia and osteoporosis by increasing bone breakdown. This may result in hypercalcemia (high levels of calcium in the blood), which can cause hypercalciuria (excessive calcium in the urine), not hypocalciuria.

Prostaglandins can maintain the patency of a patent ductus arteriosus, which can be beneficial in cases of duct dependent cardiac lesions such as tetralogy of Fallot, Ebstein’s anomaly, pulmonary atresia, and pulmonary stenosis. These conditions may be diagnosed before birth or present with symptoms such as cyanosis, tachypnea, and weak peripheral pulses at birth. While surgery is often the definitive treatment, keeping the duct open with prostaglandins can provide time for appropriate management planning. Aspirin is not recommended for children due to the risk of Reyes syndrome, which can cause liver and brain edema and be fatal. Indomethacin and other medications may also be used to close the duct.

Patent ductus arteriosus is a type of congenital heart defect that is typically classified as ‘acyanotic’. However, if left untreated, it can eventually lead to late cyanosis in the lower extremities, which is known as differential cyanosis. This condition is caused by a connection between the pulmonary trunk and descending aorta that fails to close with the first breaths due to increased pulmonary flow that enhances prostaglandins clearance. Patent ductus arteriosus is more common in premature babies, those born at high altitude, or those whose mothers had rubella infection during the first trimester of pregnancy.

The features of patent ductus arteriosus include a left subclavicular thrill, a continuous ‘machinery’ murmur, a large volume, bounding, collapsing pulse, a wide pulse pressure, and a heaving apex beat. To manage this condition, indomethacin or ibuprofen is given to the neonate, which inhibits prostaglandin synthesis and closes the connection in the majority of cases. If patent ductus arteriosus is associated with another congenital heart defect that is amenable to surgery, then prostaglandin E1 is useful to keep the duct open until after surgical repair.

In the case of an acute presentation of atrial fibrillation with signs of haemodynamic instability such as hypotension or heart failure, the correct treatment is electrical cardioversion. This is because the patient is at risk of going into cardiac arrest and needs to be returned to normal sinus rhythm immediately to prevent end organ damage. Giving a bolus of IV saline is not recommended as it will not push more blood into the ventricles and could even be harmful. Starting high dose aspirin or bisoprolol is not appropriate in this situation. Digoxin is only considered as a second line treatment for stable patients, so pharmacologic therapies are not considered until after cardioversion has been attempted and blood pressure returns to normal.

Atrial fibrillation (AF) is a condition that requires careful management to prevent complications. The latest guidelines from NICE recommend that patients presenting with AF should be assessed for haemodynamic instability, and if present, electrically cardioverted. For haemodynamically stable patients, the management depends on how acute the AF is. If the AF has been present for less than 48 hours, rate or rhythm control may be considered. However, if it has been present for 48 hours or more, or the onset is uncertain, rate control is recommended. If long-term rhythm control is being considered, cardioversion should be delayed until the patient has been maintained on therapeutic anticoagulation for at least 3 weeks.

Rate control is the first-line treatment strategy for AF, except in certain cases. Medications such as beta-blockers, calcium channel blockers, and digoxin can be used to control the heart rate. However, digoxin is no longer considered first-line as it is less effective at controlling the heart rate during exercise. Rhythm control agents such as beta-blockers, dronedarone, and amiodarone can be used to maintain sinus rhythm in patients with a history of AF. Catheter ablation is recommended for those who have not responded to or wish to avoid antiarrhythmic medication.

The aim of catheter ablation is to ablate the faulty electrical pathways that are causing AF. The procedure is performed percutaneously, typically via the groin, and can use radiofrequency or cryotherapy to ablate the tissue. Anticoagulation should be used 4 weeks before and during the procedure. It is important to note that catheter ablation controls the rhythm but does not reduce the stroke risk, so patients still require anticoagulation as per their CHA2DS2-VASc score. Complications of catheter ablation can include cardiac tamponade, stroke, and pulmonary vein stenosis. The success rate of the procedure is around 50% for early recurrence within 3 months, and around 55% of patients who’ve had a single procedure remain in sinus rhythm after 3 years. Of patients who’ve undergone multiple procedures, around 80% are in sinus rhythm.

Before administering bisphosphonates, it is important to correct any hypocalcemia or vitamin D deficiency in the patient. This is especially important for patients with metastatic prostate cancer who may experience symptoms such as muscle spasms, tingling sensations, and nausea/vomiting, which are indicative of hypocalcemia. Bisphosphonates like zoledronic acid reduce bone turnover, which can further exacerbate the effects of calcium or vitamin D deficiency on serum calcium levels. Hypercalcemia, hyperkalemia, and hypernatremia are unlikely to occur as a result of bisphosphonate therapy and are therefore incorrect options.

Bisphosphonates: Uses and Adverse Effects

Bisphosphonates are drugs that mimic the action of pyrophosphate, a molecule that helps prevent bone demineralization. They work by inhibiting osteoclasts, which are cells that break down bone tissue. This reduces the risk of bone fractures and can be used to treat conditions such as osteoporosis, hypercalcemia, Paget’s disease, and pain from bone metastases.

However, bisphosphonates can have adverse effects, including oesophageal reactions such as oesophagitis and ulcers, osteonecrosis of the jaw, and an increased risk of atypical stress fractures of the proximal femoral shaft in patients taking alendronate. Patients may also experience an acute phase response, which can cause fever, myalgia, and arthralgia. Hypocalcemia, or low calcium levels, can also occur due to reduced calcium efflux from bone, but this is usually not clinically significant.

To minimize the risk of adverse effects, patients taking oral bisphosphonates should swallow the tablets whole with plenty of water while sitting or standing. They should take the medication on an empty stomach at least 30 minutes before breakfast or other oral medications and remain upright for at least 30 minutes after taking the tablet. Hypocalcemia and vitamin D deficiency should be corrected before starting bisphosphonate treatment, and calcium supplements should only be prescribed if dietary intake is inadequate. The duration of bisphosphonate treatment varies depending on the patient’s level of risk, and some authorities recommend stopping treatment after five years for low-risk patients with a femoral neck T-score of > -2.5.

If the woman does not approve of hormonal treatments, alternatives such as tranexamic acid or NSAIDs can be utilized according to NICE CG44.

Managing Heavy Menstrual Bleeding

Heavy menstrual bleeding, also known as menorrhagia, is a condition where a woman experiences excessive blood loss during her menstrual cycle. While it was previously defined as total blood loss of over 80 ml per cycle, the management of menorrhagia now depends on the woman’s perception of what is excessive. In the past, hysterectomy was a common treatment for heavy periods, but the approach has changed significantly since the 1990s.

To manage menorrhagia, a full blood count should be performed in all women. If symptoms suggest a structural or histological abnormality, a routine transvaginal ultrasound scan should be arranged. For women who do not require contraception, mefenamic acid or tranexamic acid can be used. If there is no improvement, other drugs can be tried while awaiting referral.

For women who require contraception, options include the intrauterine system (Mirena), combined oral contraceptive pill, and long-acting progestogens. Norethisterone can also be used as a short-term option to rapidly stop heavy menstrual bleeding. The flowchart below shows the management of menorrhagia.

[Insert flowchart here]

Treatment Options for Aortic Stenosis

Aortic stenosis (AS) is a serious condition that requires prompt treatment. The gold standard treatment for symptomatic AS is surgical aortic valve replacement, which involves open-heart surgery and the use of mechanical or biological valves. However, for patients who are deemed too high risk for open-heart surgery, aortic balloon valvuloplasty or transcatheter aortic valve implantation (TAVI) may be considered as less invasive options.

Annual echocardiography monitoring is necessary to ensure the effectiveness of the treatment. It is important to note that oral nitrates are contraindicated in patients with AS as they can cause profound hypotension. Direct oral anticoagulants are also not licensed or indicated for the treatment of valvular heart disease. Overall, the choice of treatment depends on the patient’s individual risk factors and overall health status.

Understanding Geographic Tongue: Symptoms, Causes, and Treatment

Geographic tongue, also known as benign migratory glossitis, is a common condition that affects the tongue. It is characterized by irregularly shaped, red, smooth, and swollen patches on the tongue, often with a white border, giving rise to a map-like appearance. The exact cause of geographic tongue is unknown, but it has been associated with fissured tongue and has an inverse association with cigarette smoking.

Symptoms of geographic tongue include a burning sensation on the tongue, and eating acidic foods can worsen the pain. While the condition is usually self-limiting, symptomatic treatment can include topical anaesthetic preparations and/or soluble corticosteroids used as a ‘mouth rinse’.

It is important to note that geographic tongue is not a pre-malignant condition and is not associated with an increased risk of oral cancer. However, it is important to seek medical attention if you experience any unusual symptoms or changes in your oral health.

Overall, understanding the symptoms, causes, and treatment options for geographic tongue can help individuals manage their condition and maintain good oral health.

Alcohol withdrawal occurs when an individual who has been consuming alcohol chronically suddenly stops or reduces their intake. Chronic alcohol consumption enhances the inhibitory effects of GABA in the central nervous system, similar to benzodiazepines, and inhibits NMDA-type glutamate receptors. However, alcohol withdrawal leads to the opposite effect, resulting in decreased inhibitory GABA and increased NMDA glutamate transmission. Symptoms of alcohol withdrawal typically start at 6-12 hours and include tremors, sweating, tachycardia, and anxiety. Seizures are most likely to occur at 36 hours, while delirium tremens, which includes coarse tremors, confusion, delusions, auditory and visual hallucinations, fever, and tachycardia, peak at 48-72 hours.

Patients with a history of complex withdrawals from alcohol, such as delirium tremens, seizures, or blackouts, should be admitted to the hospital for monitoring until their withdrawals stabilize. The first-line treatment for alcohol withdrawal is long-acting benzodiazepines, such as chlordiazepoxide or diazepam, which are typically given as part of a reducing dose protocol. Lorazepam may be preferable in patients with hepatic failure. Carbamazepine is also effective in treating alcohol withdrawal, while phenytoin is said to be less effective in treating alcohol withdrawal seizures.

The patient’s symptoms and medical history suggest a diagnosis of lichen planus, a skin condition with an unknown cause that is likely immune-mediated. The rash is typically itchy and appears as papules with a shiny, purplish color in areas such as the palms, soles, genitalia, and flexor surfaces of the arms. The rash often has a polygonal shape and may have white lines known as Wickham’s striae. Over time, the papules flatten and are replaced by hyperpigmentation. Oral involvement is common, with a white-lace pattern on the buccal mucosa. Management usually involves topical steroids, but more severe cases may require oral steroids or immunosuppressants. Atopic eczema, irritant eczema, molluscum contagiosum, and psoriasis are different skin conditions that do not fit the patient’s symptoms.

Medical Conditions that Cause Bilateral Oedema: Inferior Vena Cava Obstruction, Hypoalbuminaemia, Deep Venous Thrombosis, Heart Failure, and Hyponatraemia

Bilateral oedema, or swelling in both legs, can be caused by various medical conditions. One of these is inferior vena cava obstruction, which occurs when a renal mass or thrombus compresses the inferior vena cava, preventing venous drainage of the lower limbs. This obstruction can also cause venous engorgement and dilated veins around the umbilicus. Hypoalbuminaemia, on the other hand, causes a generalised oedema that can be seen in the face, upper and lower limbs, and abdomen. Deep venous thrombosis, which presents with painful swelling and erythema in the affected lower limb, can also cause bilateral symptoms if it occurs in the inferior vena cava. Heart failure, which causes bilateral dependent oedema due to fluid overload, is another possible cause of bilateral oedema. Finally, severe hyponatraemia resulting from fluid overload can cause a generalised symmetrical pattern of oedema that affects the upper limbs as well. Treatment for bilateral oedema depends on the underlying cause.

Edward’s syndrome is characterized by micrognathia, low-set ears, rocker bottom feet, and overlapping of fingers, which are present at birth.

Childhood syndromes are a group of medical conditions that affect children and are characterized by a set of common features. Patau syndrome, also known as trisomy 13, is a syndrome that is characterized by microcephaly, small eyes, cleft lip/palate, polydactyly, and scalp lesions. Edward’s syndrome, also known as trisomy 18, is characterized by micrognathia, low-set ears, rocker bottom feet, and overlapping of fingers. Fragile X syndrome is characterized by learning difficulties, macrocephaly, long face, large ears, and macro-orchidism. Noonan syndrome is characterized by a webbed neck, pectus excavatum, short stature, and pulmonary stenosis. Pierre-Robin syndrome is characterized by micrognathia, posterior displacement of the tongue, and cleft palate. Prader-Willi syndrome is characterized by hypotonia, hypogonadism, and obesity. William’s syndrome is characterized by short stature, learning difficulties, friendly, extrovert personality, and transient neonatal hypercalcaemia. Cri du chat syndrome, also known as chromosome 5p deletion syndrome, is characterized by a characteristic cry, feeding difficulties and poor weight gain, learning difficulties, microcephaly and micrognathism, and hypertelorism. It is important to note that Treacher-Collins syndrome is similar to Pierre-Robin syndrome, but it is autosomal dominant and usually has a family history of similar problems.

An HbA1c level ranging from 42-47 mmol/mol suggests the presence of prediabetes. Individuals with this condition should be motivated to enhance their physical activity, shed excess weight, and adopt a healthier diet by consuming more dietary fiber and reducing fat intake. Metformin may be an option for those with prediabetes, but the initial dose should be 500mg once daily. Regular HbA1c monitoring is necessary for individuals diagnosed with prediabetes as they are at a heightened risk of developing diabetes.

Type 2 diabetes mellitus can be diagnosed through a plasma glucose or HbA1c sample. The diagnostic criteria vary depending on whether the patient is experiencing symptoms or not. If the patient is symptomatic, a fasting glucose level of 7.0 mmol/l or higher or a random glucose level of 11.1 mmol/l or higher (or after a 75g oral glucose tolerance test) indicates diabetes. If the patient is asymptomatic, the same criteria apply but must be demonstrated on two separate occasions.

In 2011, the World Health Organization released supplementary guidance on the use of HbA1c for diagnosing diabetes. A HbA1c level of 48 mmol/mol (6.5%) or higher is diagnostic of diabetes mellitus. However, a HbA1c value of less than 48 mmol/mol (6.5%) does not exclude diabetes and may not be as sensitive as fasting samples for detecting diabetes. For patients without symptoms, the test must be repeated to confirm the diagnosis. It is important to note that increased red cell turnover can cause misleading HbA1c results.

There are certain conditions where HbA1c cannot be used for diagnosis, such as haemoglobinopathies, haemolytic anaemia, untreated iron deficiency anaemia, suspected gestational diabetes, children, HIV, chronic kidney disease, and people taking medication that may cause hyperglycaemia (such as corticosteroids).

Impaired fasting glucose (IFG) is defined as a fasting glucose level of 6.1 mmol/l or higher but less than 7.0 mmol/l. Impaired glucose tolerance (IGT) is defined as a fasting plasma glucose level less than 7.0 mmol/l and an OGTT 2-hour value of 7.8 mmol/l or higher but less than 11.1 mmol/l. People with IFG should be offered an oral glucose tolerance test to rule out a diagnosis of diabetes. A result below 11.1 mmol/l but above 7.8 mmol/l indicates that the person does not have diabetes but does have IGT.

Managing Asthma in Children: NICE Guidelines

Asthma management in children has been updated by NICE in 2017, following the 2016 BTS guidelines. The new guidelines for children aged 5-16 are similar to those for adults, with a stepwise approach for treatment. For newly-diagnosed asthma, short-acting beta agonist (SABA) is recommended. If symptoms persist, a combination of SABA and paediatric low-dose inhaled corticosteroid (ICS) is used. Leukotriene receptor antagonist (LTRA) is added if symptoms still persist, followed by long-acting beta agonist (LABA) if necessary. Maintenance and reliever therapy (MART) is used as a combination of ICS and LABA for daily maintenance therapy and symptom relief. For children under 5 years old, clinical judgement plays a greater role in diagnosis. The stepwise approach is similar to that for older children, with an 8-week trial of paediatric moderate-dose ICS before adding LTRA. If symptoms persist, referral to a paediatric asthma specialist is recommended.

It should be noted that NICE does not recommend changing treatment for well-controlled asthma patients simply to adhere to the latest guidelines. The definitions of low, moderate, and high-dose ICS have also changed, with different definitions for adults and children. For children, <= 200 micrograms budesonide or equivalent is considered a paediatric low dose, 200-400 micrograms is a moderate dose, and > 400 micrograms is a high dose. Overall, the new NICE guidelines provide a clear and concise approach to managing asthma in children.

Lithium is known to cause tremors, particularly a fine non-distractible rest tremor. This side effect is more common at higher doses and in cases of toxicity, but can still occur at treatment levels. Diazepam, a medication commonly used to manage acute anxiety and tremors, is unlikely to produce any motor effects from typical use. Mirtazapine, an antidepressant, can cause tremors but it is much less common than in other antidepressants. Olanzapine, an antipsychotic medication, can also cause tremors but they are usually coarse and affect the mouth and face. Based on the description of the tremor, it is more likely that lithium is the cause.

Lithium is a medication used to stabilize mood in individuals with bipolar disorder and as an adjunct in treatment-resistant depression. It has a narrow therapeutic range of 0.4-1.0 mmol/L and is primarily excreted by the kidneys. The mechanism of action is not fully understood, but it is believed to interfere with inositol triphosphate and cAMP formation. Adverse effects may include nausea, vomiting, diarrhea, fine tremors, nephrotoxicity, thyroid enlargement, ECG changes, weight gain, idiopathic intracranial hypertension, leucocytosis, hyperparathyroidism, and hypercalcemia.

Monitoring of patients taking lithium is crucial to prevent adverse effects and ensure therapeutic levels. It is recommended to check lithium levels 12 hours after the last dose and weekly after starting or changing the dose until levels are stable. Once established, lithium levels should be checked every three months. Thyroid and renal function should be monitored every six months. Patients should be provided with an information booklet, alert card, and record book to ensure proper management of their medication. Inadequate monitoring of patients taking lithium is common, and guidelines have been issued to address this issue.